ID
30832
Description
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin This form is to be completed every 6 months once the patient has entered long-term follow-up.
Mots-clés
Versions (1)
- 25/06/2018 25/06/2018 -
Détendeur de droits
see clinicaltrials.gov
Téléchargé le
25 juin 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Long-Term Follow-Up for Survival & Disease Status
- StudyEvent: ODM
Description
Additional therapy for NHL since the last LTFU
Alias
- UMLS CUI-1
- C0024305
- UMLS CUI-2
- C1706712
Description
additional therapy for NHL
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C1706712
Description
Lymphoma, Non-Hodgkin Therapeutic procedure Following Visit
Type de données
text
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0332282
- UMLS CUI [1,4]
- C0545082
Description
Start Date, Lymphoma, Non-Hodgkin, Therapeutic procedure
Type de données
date
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0808070
Description
End date, Lymphoma, Non-Hodgkin, Therapeutic procedure
Type de données
date
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0806020
Description
chemotherapeutics regimen total number of cycles ordered, Lymphoma, Non-Hodgkin, Therapeutic procedure
Type de données
text
Alias
- UMLS CUI [1,1]
- C2045831
- UMLS CUI [1,2]
- C0024305
Description
Myelodysplasia
Alias
- UMLS CUI-1
- C0026985
Description
Myelodysplasia diagnosis
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0026985
- UMLS CUI [1,2]
- C0011900
Description
Myelodysplasia Date of diagnosis
Type de données
date
Alias
- UMLS CUI [1,1]
- C0026985
- UMLS CUI [1,2]
- C2316983
Description
AML
Alias
- UMLS CUI-1
- C0023467
Description
Another malignancy
Alias
- UMLS CUI-1
- C0006826
Description
Malignancy diagnosis
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C0011900
Description
Malignancy Date of diagnosis
Type de données
date
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C2316983
Description
TSH measurement
Alias
- UMLS CUI-1
- C0202230
Description
TSH measurement Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C0011008
Description
TSH measurement Result
Type de données
float
Unités de mesure
- µIU/mL
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C1254595
Description
TSH measurement Not done
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C1272696
Description
HAMA
Alias
- UMLS CUI-1
- C1291910
Similar models
Long-Term Follow-Up for Survival & Disease Status
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1706712 (UMLS CUI-2)
C1706712 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0332282 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C0024305 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1254595 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])
C3872643 (UMLS CUI [1,2])
C1510755 (UMLS CUI [1,2])
Aucun commentaire